1. Home
  2. RVSB vs INO Comparison

RVSB vs INO Comparison

Compare RVSB & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.27

Market Cap

106.9M

Sector

Finance

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
INO
Founded
1923
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.9M
100.4M
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
RVSB
INO
Price
$5.27
$1.18
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$7.00
$6.75
AVG Volume (30 Days)
200.8K
1.5M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
N/A
$42,220,086.00
Revenue This Year
$53.63
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$4.74
$1.03
52 Week High
$6.22
$2.86

Technical Indicators

Market Signals
Indicator
RVSB
INO
Relative Strength Index (RSI) 38.99 51.80
Support Level $5.24 $1.03
Resistance Level $5.47 $1.24
Average True Range (ATR) 0.21 0.06
MACD -0.04 0.01
Stochastic Oscillator 10.22 53.85

Price Performance

Historical Comparison
RVSB
INO

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment services. It has single operating segment.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: